VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
ALLO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
ALLOAllogene Therapeutics, Inc.
$1.50$518M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksALLOPrice History

ALLO logoAllogene Therapeutics, Inc. (ALLO) Stock Price History

Historical prices from 2018 to 2026

$1.50-0.04  (-2.60%)close Oct 2
Returns
1M
-24.2%
3M
-27.9%
YTD
+11.1%
1Y
+16.3%
3Y
-21.5%
5Y
-42.7%
ATH$55.00May 2020-97.3%
ATL$0.86May 2025pre-split
Avg Vol (50D)5.7M/ day
52-Week Range$1.04 — $4.46
LowCurrent: $1.50High

Loading 10-year price history...

ALLO Historical Performance

1 YearTotal Return
+16.3%
Price: +16.3%
3 YearsTotal Return
-51.6%
CAGR: -21.5%
Price: -51.6%
5 YearsTotal Return
-93.8%
CAGR: -42.7%
Price: -93.8%
YTD
+11.1%

ALLO Annual Returns

Year-by-year price performance · 2018–2026

Best+7.7%2018
Worst-58.9%2022
Up years2/9
2018+7.7%
2019-5.7%
2020-3.7%
2021-42.1%
2022-58.9%
2023-44.3%
2024-41.2%
2025-37.7%
2026+39.3%
2018 annual price return
+7.7%
2019 annual price return
-5.7%
2020 annual price return
-3.7%
2021 annual price return
-42.1%
2022 annual price return
-58.9%
2023 annual price return
-44.3%
2024 annual price return
-41.2%
2025 annual price return
-37.7%
2026 annual price return
+39.3%
LessMore
Alpha vs S&P 500
1Y+1.3%
3Y-42.5%
5Y-54.9%

Price returns only.

Download Historical Data

2,004 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ALLO Stock Price Trajectory (2018–2026)

As of October 3, 2026, Allogene Therapeutics, Inc. (ALLO) trades at $1.50, representing a +16.3% return over the past year. The stock has delivered a -93.8% total return over five years (-42.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $55.00 on May 26, 2020. From this peak, ALLO has corrected -97.3%, currently trading 25% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers CRSP (-23.9% 1Y), FATE (+91.7% 1Y), and BEAM (-4.3% 1Y), ALLO has underperformed the peer group average. Compare ALLO vs CRSP →

ALLO Historical Price Data · from 2018

Rows 1–50 of 2,004
Date Open High Low Close Volume Change %
2026-10-021.571.571.501.504.61M-2.60%
2026-10-011.581.611.531.544.57M-3.75%
2026-09-301.611.661.581.608.04M-1.23%
2026-09-291.621.651.601.624.44M-0.61%
2026-09-281.641.671.601.635.02M-1.21%
2026-09-251.701.701.631.653.62M-1.20%
2026-09-241.671.721.601.677.74M0.00%
2026-09-231.731.731.651.675.90M-2.34%
2026-09-221.721.741.681.715.22M+1.18%
2026-09-211.711.721.651.694.30M0.00%
2026-09-181.731.731.671.6912.72M-2.31%
2026-09-171.751.761.701.733.94M+2.37%
2026-09-161.741.771.661.695.60M-1.74%
2026-09-151.801.801.711.723.13M-3.37%
2026-09-141.791.831.771.787.73M0.00%
2026-09-111.801.801.751.783.88M+1.14%
2026-09-101.731.781.701.765.40M+1.73%
2026-09-091.771.881.721.737.21M-6.99%
2026-09-081.931.941.851.867.43M-5.58%
2026-09-041.952.011.951.974.42M-0.51%
2026-09-032.002.011.921.984.42M0.00%
2026-09-021.972.041.911.985.39M-0.25%
2026-09-011.982.001.931.994.03M-0.75%
2026-08-312.002.021.962.004.37M-0.99%
2026-08-282.082.092.002.023.82M-3.35%
2026-08-272.042.142.002.094.96M+2.45%
2026-08-262.172.182.032.045.00M-5.99%
2026-08-252.052.212.052.176.16M+6.90%
2026-08-242.112.112.002.034.76M-2.87%
2026-08-212.122.152.062.094.37M-0.48%
2026-08-202.192.212.072.104.86M-5.83%
2026-08-192.082.232.082.236.71M+9.85%
2026-08-182.072.092.002.034.09M-2.40%
2026-08-172.052.102.022.084.68M+1.46%
2026-08-141.962.081.922.054.61M+3.54%
2026-08-132.132.161.961.986.34M-4.35%
2026-08-122.132.152.052.074.58M-2.36%
2026-08-112.112.192.072.124.97M+0.95%
2026-08-101.992.101.982.105.36M+4.48%
2026-08-071.982.031.962.013.70M+2.03%
2026-08-061.951.991.921.973.17M+1.03%
2026-08-051.901.981.901.955.06M+2.63%
2026-08-041.871.911.821.905.00M+3.26%
2026-08-031.871.901.811.847.04M-2.13%
2026-07-311.972.001.861.885.52M-4.57%
2026-07-301.862.001.861.9710.52M+8.84%
2026-07-291.721.881.651.8112.52M+9.04%
2026-07-281.751.761.611.669.96M-5.14%
2026-07-271.801.911.751.756.90M+0.57%
2026-07-241.831.841.741.744.87M-4.40%
…
Consensus & Technical Research Suite
Open ALLO Terminal

ALLO Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ALLO — Frequently Asked Questions

Quick answers to the most common questions about buying ALLO stock.

How has ALLO stock performed recently?

ALLO returned +16.3% over the past year, beating its 5-year annualized CAGR of -42.7%. The stock trades below its 200-day moving average, confirming the uptrend.

What is ALLO's all-time high price?

Allogene Therapeutics, Inc. reached $55.00 on 2020-05-26. The 52-week high is $4.46. Current 1-year return of +16.3% places the stock closer to historical peaks.

Where can I download ALLO historical price data?

This page provides ALLO daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2018-2026, downloadable in CSV format.

402 data points · sampled from 2,004